After the UK approval, everything concerning DCVax will move lightening speed. Tumor shrinkage will be adopted as primary ending point and it will take months to draw definitive conclusion. Have we seen trials like that often? ABSOLUTELY NO.
BTW, if I am not mistaken, it seems like tumor shrinkage can be used as outcome measure for both DCVax-L and Direct. I can understand it for the Direct. I don't understand it for L. Does this mean they don't need to remove all the tissues surrounding tumors and they just need enough tumor tissues to make the vaccine?